15 digital health startups to benefit from new program

Fifteen digital health companies are set to benefit from national digital health commercialisation organisation ANDHealth’s accelerator program, supported by LaunchVic.

The new ANDHealth Activate program, designed specifically for the Victorian SME community, will see cohort companies participate in a highly customised initiative that will support them to scale up and navigate the complex commercialisation pathway in digital and connected health, ultimately supporting them to raise capital, secure enterprise customers and enter new international markets.

The 15 companies selected for the 2023 ACTIVATE first cohort are:

PerfusionMap: Empowering anaesthetists and intensive care doctors to better manage perfusion, improving clinical outcomes and decreasing ICU length-of-stay.

Humanetix: Providing the only care management platform in Australia that has been independently proven to help Aged Care operators stay ahead of the demands of the digital era.

Cyber Clinic: Changing the way you access mental health care by matching clients and their mental health professionals based on needs and expertise rather than location.

GenoVic: A clinical genomics platform that enables the delivery of genomic medicine at scale.

Optiscan Imaging: Optiscan is a global leader in the development, manufacture and commercialisation of endomicroscopic digital imaging technology solutions for medical, translational and pre-clinical applications.

Lenexa Medical: Providing LenexaCARE, a revolutionary solution for the effective management of pressure injuries in hospitals, aged and in-home care.

CollabCare: Making the lives of our elders a little better through purpose-built digital health solutions. Their FamilyShare solution supports people living with dementia through better connection with their loved ones and their cherished memories.

Kontent Labs: Providing edtech for medtech: white-label, no-code platform for trusted clinical channel education, accreditation and commercialisation.

Tournicare: Developing a next-generation blood pressure management system (ARMA) that empowers healthcare professionals and patients to more effectively diagnose and manage blood pressure to reduce cardiovascular disease.

Virtetic: Leveraging the power of virtual reality and wearable sensors to make rehabilitation and prosthesis use training fun for people living with limb loss and to empower clinicians to make data-driven decisions.

Diag-Nose Medical: Developing AI-enabled laboratory tests to help ear, nose and throat (ENT) specialists with improved patient access, triage, treatment selection and monitoring for patients suffering from chronic nasal disorders.

Siara Health: Digital tools to educate and engage with patients before and after surgery, providing individually tailored medical information, reminders and outcome data for improved patient outcomes.

Alerte Digital Health: Using artificial intelligence to semi-automate or automate ECG and Echo procedures processes. By using AI, Alerte’s applications can introduce efficiencies, reliability, consistency and greater accuracy across many medical locations, consumer applications and medical devices.

Cape Bionics: Producing custom-fit compression garments from a 3D scan.

SmartHeal: Developing an end-to-end wound care platform to improve the management and negative patient outcomes of chronic wounds.

ANDHealth Managing Director and CEO Bronwyn Le Grice said, “Victoria currently represents 39% of Australia’s evidence-based digital and connected health sector, making it an ideal place in which to design and deliver the next cutting-edge commercialisation program in the ANDHealth program suite.”

The new program brings together a unique combination of elements from our flagship programs, into a free 6-month program which provides hands-on support, mentorship, pre-vetted and curated industry experts and access to global industry leaders, focused on supporting companies to become investment and enterprise customer ready, Le Grice said.

Victorian CEO and Founder of VaxApp Luke Renehan, who has participated in previous ANDHealth programs, supported the approach: “These programs are world class. ANDHealth has given us access to potential partners, clients, investors, advisors, funding, new international markets and insights from global leaders we would not have had access to otherwise.”

The inaugural cohort announcement follows ANDHealth being awarded $1.4m in funding from LaunchVic to establish a novel accelerator program for high-growth-potential digital health startups in October 2022.

The funding will be used by ANDHealth to run ACTIVATE three times over three years out of the Victorian Connected Health Innovation and Commercialisation Centre (CHICC) based in the Melbourne CBD.

This year’s cohort was selected through a competitive screening process by ANDHealth’s multi-disciplinary and multi-sectoral selection judging panel.

Image caption: iStockphoto.com/Mironov Konstantin